✦ LIBER ✦

Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

✍ Scribed by Scott A. Halperin; Joanne M. Langley; Bruce Smith; Peter Wunderli; Lisa Kaufman; Alan Kimura; Denis Martin

Book ID: 116959224
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 140 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2006.08.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the safety, reactogenicity

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

✍ C. Van Hoecke; M. Comberbach; D. De Grave; P. Desmons; D. Fu; P. Hauser; E. Leba 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 894 KB

A Novel Intramuscular Bivalent Norovirus

A Novel Intramuscular Bivalent Norovirus Virus-Like Particle Vaccine Candidate--Reactogenicity, Safety, and Immunogenicity in a Phase 1 Trial in Healthy Adults

✍ Treanor, J. J.; Atmar, R. L.; Frey, S. E.; Gormley, R.; Chen, W. H.; Ferreira, J 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 601 KB

A phase 2 open-label safety and immunoge

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults

✍ Marshall, Helen S.; Richmond, Peter C.; Nissen, Michael D.; Wouters, Ann; Baber, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 633 KB

Phase I/II studies to evaluate safety an

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein–Barr virus vaccine in healthy adults

✍ Moutschen, Michel (author);Léonard, Philippe (author);Sokal, Etienne M. (author) 📂 Article 📅 2007 🏛 Elsevier BV 🌐 English ⚖ 148 KB

A placebo-controlled dose response study

A placebo-controlled dose response study of the reactogenicity and immunogenicity of a live cold-recombinant influenza B virus vaccine in healthy volunteers

✍ Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v

A randomized, open-label study of the im

A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults

✍ Micha Loebermann; Herwig Kollaritsch; Tom Ziegler; Pamela Rendi-Wagner; Laurent 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 604 KB